Tubal, Lady Jane C.
HRN: 26-54-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2025
CIPROFLOXACIN 500MG (TAB)
01/21/2025
01/28/2025
PO
500mg
Q24h
UTI
Waiting Final Action
Indication: Empiric Then Culture-directed Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes